How Michael J. Fucci’s Appointment Reinforces Acadia Healthcare’s Commitment to Enhanced Board Governance
Acadia Healthcare Company, Inc. has recently announced the appointment of Michael J. Fucci as an independent director on its Board of Directors, effective immediately. This appointment marks a significant addition to Acadia’s leadership team, expanding the board to nine members, with eight of these being independent.
Michael J. Fucci brings a wealth of experience to Acadia Healthcare, particularly from his notable career at Deloitte U.S., where he served as Chairman Emeritus until his retirement in September 2020. His extensive tenure at Deloitte included roles such as Executive Chairman from 2015 to 2019 and Chief Operating Officer of Deloitte Consulting from 2009 to 2015. During his time at Deloitte, Fucci played a pivotal role in governance and operational leadership across multiple critical areas, including organizational strategy, leadership succession, and risk mitigation.
Acadia Healthcare, headquartered in Franklin, Tennessee, is recognized as a leading provider of behavioral healthcare services. As of mid-2020, it operated a vast network of 589 facilities, offering approximately 18,200 beds across 40 states, the United Kingdom, and Puerto Rico. The organization provides a comprehensive range of services in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.
The addition of Fucci to the Acadia Board is expected to enhance the company’s strategic direction. Reeve B. Waud, Chairman of Acadia’s Board, expressed enthusiasm about Fucci’s appointment, highlighting his extensive leadership experience and unique insights into human resource transformation and corporate talent strategies. Waud stated that Fucci’s expertise would greatly complement the existing board members as Acadia pursues its growth strategy and aims to deliver long-term value for stockholders.
In his own words, Fucci conveyed his honor in joining Acadia’s Board and expressed a keen interest in supporting the organization’s vital role as a leading behavioral healthcare provider. He acknowledged the increased demand for such services, particularly in light of challenges posed by the COVID-19 pandemic, and emphasized the importance of Acadia’s mission in providing quality care to those in need.
Fucci’s leadership at Deloitte included significant contributions to the Deloitte U.S. Board of Directors, where he led essential committees focused on risk and regulatory issues, as well as performance evaluation and compensation for executive leaders. His governance experience is expected to serve Acadia well as the company navigates the complexities of the behavioral healthcare landscape.
Acadia Healthcare’s commitment to expanding its services and enhancing the quality of care aligns with Fucci’s vision for corporate growth and risk management. With the newly appointed director on board, Acadia is poised to leverage his insights to better adapt to evolving industry challenges while continuing to fulfill its mission of providing exceptional behavioral healthcare.
As Acadia Healthcare continues to grow and evolve, the integration of experienced leaders like Mike Fucci into its Board of Directors signals a promising future for the organization, ensuring that it remains at the forefront of the behavioral healthcare sector.